CAMP4 Therapeutics Corporation

NASDAQ:CAMP

Biotechnology

Healthcare
$4.10 +2.42%

+$0.10 today

Market cap
$257.29M
Beta
0.08
P/E (TTM)
-2.8
EPS (TTM)
-$1.49
52W Low $1.31High $7.75

Volume 0.19M

Average 0.10M

CAMP Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

CAMP4 Therapeutics CorporationNASDAQ: CAMP

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q1 FY2026 weighted avg shares (diluted) of 57.92M shares rose 197.0% year over year, ahead of the +102.0% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 11.6% from the prior quarter.

Context

  • Weighted avg shares (diluted) increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +197.0% holds above the trailing-twelve-month pace of +102.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
57.92M+11.6% QoQ
Last fiscal yearDec 2025
30.38M+55.8% YoY
LTMMar 2026
37.54M+102.0% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+197.0%——
1 year+55.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
30.38M USD
Year-over-year change
+55.8%
4-year CAGR
-3.7%

Weighted Avg Shares (Diluted) vs competitors

How CAMP compares with its peers on the latest reported figures

  • CAMP's LTM Mar 2026 weighted avg shares (diluted) of 37.54M shares is the lowest of the 9 companies compared; the peer median is 55.18M shares.
  • Its year-over-year change of +102.0% is the 2nd highest of 9, against a peer median of +17.8%.
CAMP Competitors Peer median
Weighted Avg Shares (Diluted) for CAMP and competitors
Company Period LTM YoY 3-year CAGR
VXRTVaxart, Inc.LTM Mar 2026232.46M +14.7%-22.1%
UNCYUnicycive Therapeutics, Inc.LTM Mar 2026107.08M +1045.8%+372.5%
ATYRaTyr Pharma, Inc.LTM Mar 202695.83M +20.8%+48.5%
BMEABiomea Fusion, Inc.LTM Mar 202656.46M +55.6%+21.3%
ALXOALX Oncology Holdings Inc.LTM Mar 202653.9M +2.3%+9.7%
PMVPPMV Pharmaceuticals, Inc.LTM Mar 202652.9M +2.4%+4.8%
HYFTMindWalk Holdings Corp.LTM Jan 202641.36M +43.8%+19.2%
ACRVAcrivon Therapeutics, Inc. Common StockLTM Mar 202638.56M +2.3%+20.7%
CAMPCAMP4 Therapeutics CorporationLTM Mar 202637.54M +102.0%—
Peer median (excluding CAMP) 55.18M+17.8%+20.0%

Competitors are the stored peer set for CAMP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Feb 2022
FY2022
Feb 2023
FY2023
Nov 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue295.84M0350K652K3.5M
Cost of Revenue173.95M0001.64M
Gross Profit121.89M(947K)350K652K1.86M
Gross Margin41.2%—100.0%100.0%53.1%
Research & Development28.44M34.77M40.62M38.82M38.2M
Selling, General & Admin100.9M10.23M11.61M14.92M17.36M
Operating Expenses134.76M45M52.23M53.74M53.92M
Depreciation & Amortization22.8M878K1.68M1.7M1.64M
EBITDA7.49M(44.12M)(50.2M)(51.39M)(50.42M)
EBITDA Margin2.5%—-14343.1%-7882.2%-1441.5%
Operating Income(15.31M)(45M)(51.88M)(53.09M)(52.06M)
Operating Margin-5.2%—-14822.6%-8142.3%-1488.3%
Interest Income002.81M1.33M2.17M
Interest Expense15.32M6.26M000
Other Income / Expenses(14.75M)809K2.59M1.3M(28.34M)
Income Before Tax(30.06M)(44.19M)(49.29M)(51.79M)(80.4M)
Pre-Tax Margin-10.2%—-14083.1%-7943.4%-2298.5%
Income Tax Expense1.09M0000
Net Income(31.15M)(44.19M)(49.29M)(51.79M)(80.4M)
Net Margin-10.5%—-14083.1%-7943.4%-2298.5%
EPS (Basic)(0.88)(0.90)(4.07)(2.66)(2.65)
EPS (Diluted)(0.88)(0.90)(4.07)(2.66)(2.65)
Weighted Avg Shares35.25M36.1M12.12M19.51M30.38M
Weighted Avg Shares (Diluted)35.25M36.13M12.12M19.51M30.38M

CAMP4 Therapeutics Corporation

NASDAQ:CAMP

Intrinsic Alpha fair value

Locked

Current Price

$4.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.